Gastrointestinal complications in renal transplant recipients

Claudio Ponticelli, Patrizia Passerini

Research output: Contribution to journalArticle

Abstract

Gastrointestinal complications are frequent in renal transplant recipients and can include oral lesions, esophagitis, peptic ulcer, diarrhea, colon disorders and malignancy. Oral lesions may be caused by drugs such as cyclosporine and sirolimus, by virus or fungal infections. Leukoplakia may develop in patients with Epstein-Barr virus (EBV) infection. The commonest esophageal disorder is represented by fungal esophagitis usually caused by candida. A number of patients may suffer from nausea, vomiting and gastric discomfort. These disorders are more frequent in patients treated with mycophenolate mofetil (MMF). Peptic ulcer is more rare than in the past. Patients with a history of peptic ulcer are particularly prone to this complication. Other gastroduodenal disorders are caused by cytomegalovirus (CMV) and herpes simplex infection. Diarrhea is a frequent disorder which may be caused by pathogen microorganisms or by immunosuppressive agents. The differential diagnosis may be difficult. Colon disorders mainly consist of hemorrhage, usually sustained by CMV infection, or perforation which may be caused by diverticulitis or intestinal ischemia. Colon cancer, anal carcinoma, and EBV-associated lymphoproliferative disorders are particularly frequent in transplant recipients. A particular gastric lymphoma called mucosa-associated lymphoid tissue (MALT) lymphoma may develop in renal transplant patients. It usually responds to the eradication of Helicobacter pylori.

Original languageEnglish
Pages (from-to)643-650
Number of pages8
JournalTransplant International
Volume18
Issue number6
DOIs
Publication statusPublished - Jun 2005

Fingerprint

Kidney
Peptic Ulcer
Marginal Zone B-Cell Lymphoma
Esophagitis
Diarrhea
Colon
Mycophenolic Acid
Leukoplakia
Diverticulitis
Herpes Simplex
Epstein-Barr Virus Infections
Lymphoproliferative Disorders
Mycoses
Cytomegalovirus Infections
Virus Diseases
Sirolimus
Immunosuppressive Agents
Cytomegalovirus
Human Herpesvirus 4
Candida

Keywords

  • Gastrointestinal complications
  • Immunosuppressive therapy
  • Renal transplantation
  • Renal transplantation complications

ASJC Scopus subject areas

  • Transplantation

Cite this

Gastrointestinal complications in renal transplant recipients. / Ponticelli, Claudio; Passerini, Patrizia.

In: Transplant International, Vol. 18, No. 6, 06.2005, p. 643-650.

Research output: Contribution to journalArticle

Ponticelli, Claudio ; Passerini, Patrizia. / Gastrointestinal complications in renal transplant recipients. In: Transplant International. 2005 ; Vol. 18, No. 6. pp. 643-650.
@article{ea498a63ec1544899a3cf87ddf9b8ea9,
title = "Gastrointestinal complications in renal transplant recipients",
abstract = "Gastrointestinal complications are frequent in renal transplant recipients and can include oral lesions, esophagitis, peptic ulcer, diarrhea, colon disorders and malignancy. Oral lesions may be caused by drugs such as cyclosporine and sirolimus, by virus or fungal infections. Leukoplakia may develop in patients with Epstein-Barr virus (EBV) infection. The commonest esophageal disorder is represented by fungal esophagitis usually caused by candida. A number of patients may suffer from nausea, vomiting and gastric discomfort. These disorders are more frequent in patients treated with mycophenolate mofetil (MMF). Peptic ulcer is more rare than in the past. Patients with a history of peptic ulcer are particularly prone to this complication. Other gastroduodenal disorders are caused by cytomegalovirus (CMV) and herpes simplex infection. Diarrhea is a frequent disorder which may be caused by pathogen microorganisms or by immunosuppressive agents. The differential diagnosis may be difficult. Colon disorders mainly consist of hemorrhage, usually sustained by CMV infection, or perforation which may be caused by diverticulitis or intestinal ischemia. Colon cancer, anal carcinoma, and EBV-associated lymphoproliferative disorders are particularly frequent in transplant recipients. A particular gastric lymphoma called mucosa-associated lymphoid tissue (MALT) lymphoma may develop in renal transplant patients. It usually responds to the eradication of Helicobacter pylori.",
keywords = "Gastrointestinal complications, Immunosuppressive therapy, Renal transplantation, Renal transplantation complications",
author = "Claudio Ponticelli and Patrizia Passerini",
year = "2005",
month = "6",
doi = "10.1111/j.1432-2277.2005.00134.x",
language = "English",
volume = "18",
pages = "643--650",
journal = "Transplant International",
issn = "0934-0874",
publisher = "Blackwell Publishing Ltd",
number = "6",

}

TY - JOUR

T1 - Gastrointestinal complications in renal transplant recipients

AU - Ponticelli, Claudio

AU - Passerini, Patrizia

PY - 2005/6

Y1 - 2005/6

N2 - Gastrointestinal complications are frequent in renal transplant recipients and can include oral lesions, esophagitis, peptic ulcer, diarrhea, colon disorders and malignancy. Oral lesions may be caused by drugs such as cyclosporine and sirolimus, by virus or fungal infections. Leukoplakia may develop in patients with Epstein-Barr virus (EBV) infection. The commonest esophageal disorder is represented by fungal esophagitis usually caused by candida. A number of patients may suffer from nausea, vomiting and gastric discomfort. These disorders are more frequent in patients treated with mycophenolate mofetil (MMF). Peptic ulcer is more rare than in the past. Patients with a history of peptic ulcer are particularly prone to this complication. Other gastroduodenal disorders are caused by cytomegalovirus (CMV) and herpes simplex infection. Diarrhea is a frequent disorder which may be caused by pathogen microorganisms or by immunosuppressive agents. The differential diagnosis may be difficult. Colon disorders mainly consist of hemorrhage, usually sustained by CMV infection, or perforation which may be caused by diverticulitis or intestinal ischemia. Colon cancer, anal carcinoma, and EBV-associated lymphoproliferative disorders are particularly frequent in transplant recipients. A particular gastric lymphoma called mucosa-associated lymphoid tissue (MALT) lymphoma may develop in renal transplant patients. It usually responds to the eradication of Helicobacter pylori.

AB - Gastrointestinal complications are frequent in renal transplant recipients and can include oral lesions, esophagitis, peptic ulcer, diarrhea, colon disorders and malignancy. Oral lesions may be caused by drugs such as cyclosporine and sirolimus, by virus or fungal infections. Leukoplakia may develop in patients with Epstein-Barr virus (EBV) infection. The commonest esophageal disorder is represented by fungal esophagitis usually caused by candida. A number of patients may suffer from nausea, vomiting and gastric discomfort. These disorders are more frequent in patients treated with mycophenolate mofetil (MMF). Peptic ulcer is more rare than in the past. Patients with a history of peptic ulcer are particularly prone to this complication. Other gastroduodenal disorders are caused by cytomegalovirus (CMV) and herpes simplex infection. Diarrhea is a frequent disorder which may be caused by pathogen microorganisms or by immunosuppressive agents. The differential diagnosis may be difficult. Colon disorders mainly consist of hemorrhage, usually sustained by CMV infection, or perforation which may be caused by diverticulitis or intestinal ischemia. Colon cancer, anal carcinoma, and EBV-associated lymphoproliferative disorders are particularly frequent in transplant recipients. A particular gastric lymphoma called mucosa-associated lymphoid tissue (MALT) lymphoma may develop in renal transplant patients. It usually responds to the eradication of Helicobacter pylori.

KW - Gastrointestinal complications

KW - Immunosuppressive therapy

KW - Renal transplantation

KW - Renal transplantation complications

UR - http://www.scopus.com/inward/record.url?scp=23244451207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23244451207&partnerID=8YFLogxK

U2 - 10.1111/j.1432-2277.2005.00134.x

DO - 10.1111/j.1432-2277.2005.00134.x

M3 - Article

C2 - 15910287

AN - SCOPUS:23244451207

VL - 18

SP - 643

EP - 650

JO - Transplant International

JF - Transplant International

SN - 0934-0874

IS - 6

ER -